miR-16, 155, 125b, 374a
|
predictive of overall survival (P = 0.05) |
[307] |
miR-16, 125b, 374a, 374b, 421, 655, 497
|
predictive of distant-disease free survival (P = 0.009) |
[307] |
miR-1307, 103, 328, 83, 874, 484, 148b
|
associated with overall survival across different clinical and molecular subclasses |
[308] |
miR-767-3p, 128a, 769–3, 135a, and miR-27b, 144, 210, 42, 150, 30c
|
associated with DRFS in estrogen receptor |
[309] |
miR-335, 337-5p, 451, 486-3p, 520a-5p, 548d-5p, 15a, 24, 29a, 30b, 320, 342-5p, 342-3p
|
associated with inflammatory breast cancer |
[310] |
miR-150, 155, 142
|
have strong positive correlation to the immune response module |
[311] |
miR-130b, 19a, 449a, 299, 154, 145
|
association with proliferation |
[311] |
miR-29c
|
associated with cell adhesion/extra cellular matrix |
[311] |
miR-125b, miR-182 and miR-183
|
highly overexpressed in ductal carcinoma in situ
|
[312] |
miR-200c, miR-205, and miR-375
|
down-regulated miRNAs in invasive cell lines |
[313] |